Difficulty: Medium
Average Score: 64%
Practice
A patient develops antibiotic-associated pseudomembranous colitis (AAPMC) in response to drug therapy. Which of the following was the most likely cause of this severe problem?
Correct answer
C
Rationale
In this scenario, the correct answer is C) Clindamycin. Clindamycin is a broad-spectrum antibiotic known to disrupt the normal balance of bacteria in the gut, leading to AAPMC. This condition is caused by the overgrowth of Clostridium difficile bacteria in response to antibiotic therapy, particularly with agents like clindamycin.
Amoxicillin (A) and azithromycin (B) are not typically associated with causing AAPMC. Amoxicillin is more commonly linked to allergic reactions and not disrupting gut flora to the extent of causing pseudomembranous colitis. Azithromycin is generally considered to have a lower risk of causing this condition compared to clindamycin.
Metronidazole (D) is an antibiotic but is not a typical cause of AAPMC. Metronidazole is actually used as a treatment for Clostridium difficile infections and would not be the primary culprit in causing AAPMC.
This question is important in the context of chemotherapy drugs as patients undergoing chemotherapy often have compromised immune systems and are at higher risk of developing infections, which may require antibiotic therapy. Understanding the potential side effects and complications of different antibiotics is crucial for healthcare providers managing these vulnerable patients.
Amoxicillin (A) and azithromycin (B) are not typically associated with causing AAPMC. Amoxicillin is more commonly linked to allergic reactions and not disrupting gut flora to the extent of causing pseudomembranous colitis. Azithromycin is generally considered to have a lower risk of causing this condition compared to clindamycin.
Metronidazole (D) is an antibiotic but is not a typical cause of AAPMC. Metronidazole is actually used as a treatment for Clostridium difficile infections and would not be the primary culprit in causing AAPMC.
This question is important in the context of chemotherapy drugs as patients undergoing chemotherapy often have compromised immune systems and are at higher risk of developing infections, which may require antibiotic therapy. Understanding the potential side effects and complications of different antibiotics is crucial for healthcare providers managing these vulnerable patients.